SCM
VKTX icon

Soleus Capital Management’s Viking Therapeutics VKTX Stock Holding History

Soleus Capital Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-70,000
Closed -$2.46M – 115
2025
Q4 		$2.46M Buy
+70,000
New +$2.48M 0.1% 77
2024
Q2 		– Sell
-67,121
Closed -$5.5M – 113
2024
Q1 		$5.5M Sell
67,121
-369,079
-85% -$16.4M 0.48% 64
2023
Q4 		$8.12M Buy
436,200
+314,000
+257% +$4.11M 0.9% 36
2023
Q3 		$1.35M Sell
122,200
-214,500
-64% -$3.07M 0.14% 75
2023
Q2 		$5.46M Sell
336,700
-123,300
-27% -$2.58M 0.61% 46
2023
Q1 		$7.66M Buy
+460,000
New +$4.75M 0.95% 36

Other funds holding VKTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return